4.5 Article

Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization

Journal

VACCINE
Volume 28, Issue 20, Pages 3582-3587

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.02.088

Keywords

Antibody secreting cells; Plasmablasts; Influenza

Funding

  1. NCRR NIH HHS [M01 RR000044-430763, M01 RR000044-430761, M01 RR000044] Funding Source: Medline
  2. NIAID NIH HHS [L30 AI057621-02, U01 AI045969, K23 AI67501, N01-AI-500209, L30 AI057621-01, K23 AI067501-05, U01AI045969, L30 AI057621, L30 AI057621-03, K23 AI067501, R24 AI054953] Funding Source: Medline

Ask authors/readers for more resources

Upon vaccination, B cells differentiate into antibody secreting cells (ASCs) that migrate via the circulation to tissues. The kinetics of this response and the relationship of circulating ASCs to protective antibody titers have not been completely explored. Methods: Influenza-specific and total-IgG ASCs were enumerated by Elispot and flow cytometry daily in the blood in 6 healthy adults after trivalent influenza vaccination (TIV). Results: Peak H1-specific IgG ASC frequencies occurred variably from day 5 to 8 and correlated with the fold-rise rise in hemagglutination inhibition (HAI titers); r=0.91, p=0.006. H3-specific IgG ASC frequencies correlated less well, perhaps due to a mismatch of the H3 protein in the vaccine and that used in the Elispot assay. Peak frequencies of vaccine-specific and total-IgG ASCs were 0.3% and 0.8%, respectively, of peripheral blood mononuclear cells (PBMC). Peak TIV-, H1-, H3-, and total-IgG ASC frequencies were 1736 +/- 1133, 626 +/- 520, 592 +/- 463, and 4091 +/- 2019 spots/10(6) PBMC, respectively. Peak TIV-, H1-, and H3-specific IgG ASC of total-IgG ASC frequencies constituted 63% +/- 21, 26% +/- 10, 22% +/- 17, respectively. Conclusion: After immunization with inactivated influenza vaccine the peak in influenza-specific ASC frequencies is variable but correlates well with the magnitude of protective HAI responses. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available